ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	ClinicalTrials.gov
Last refreshed on:	16 December 2017
Main ID:	NCT02257931
Date of registration:	02/10/2014
Prospective Registration:	No
Primary sponsor:	European Group for Blood and Marrow Transplantation
Public title:	Gram-negative Bacteremia in HSCT Recipients GNB
Scientific title:	Resistance Pattern of Gram-negative Bacteria Isolated From Blood From HSCT Recipients.
Date of first enrolment:	February 2014
Target sample size:	591
Recruitment status:	Completed
URL:	https://clinicaltrials.gov/show/NCT02257931
Study type:	Observational [Patient Registry]
Study design:
Phase:	N/A

Countries of recruitment
Belgium	China	Croatia	Germany	Israel	Portugal	Russian Federation	Sweden
Turkey

Contacts

Name:	Dina Averbuch, MD
Address:
Telephone:
Email:
Affiliation:	Hadassah University Hospital, Pediatric Infectious Diseases Unit, Jerusalem, Israel

Name:	Simone Cesaro, MD
Address:
Telephone:
Email:
Affiliation:	Policlinico G.B. Rossi, paediatric haematology oncology, Verona, Italy

Name:	Dan Engelhard, MD
Address:
Telephone:
Email:
Affiliation:	Hadassah University Hospital, Pediatric Infectious Diseases Unit, Jerusalem, Israel

Key inclusion & exclusion criteria

Inclusion Criteria:

- Allogeneic or autologous HSCT recipients, of all ages, for any indications.

Exclusion Criteria:

- Patients who are not willing to participate.

Age minimum: N/A
Age maximum: N/A
Gender: All

Health Condition(s) or Problem(s) studied

Allogeneic or Autologous HSCT

Intervention(s)

Primary Outcome(s)

The proportion of resistant pathogens among gram-negative bacterial pathogens isolated from blood of HSCT recipients during the first 6 months post HSCT. [Time Frame: 6 months after HSCT]

Secondary Outcome(s)

The proportion of resistant Gram-negative pathogens not listed in the primary end-point among Gram-negative bacterial pathogens isolated from blood of HSCT recipients during the first 6 months post HSCT: [Time Frame: 6 months after HSCT]

Secondary ID(s)

8414106

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Ethics review

Results

Results available:
Date Posted:
Date Completed:
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.